IL2 and Alzheimer disease: In addition, intravenous administration of HA-MMSN-1F12 increased the production and release of inflammatory cytokines, including IL-2, IL-4, and IL-10, resulting in anti-inflammatory responses (Figure 7D), promoting the improvement of neuroinflammation in AD.